Lakewood-Amedex Biotherapeutics, Inc.

Lakewood-Amedex Biotherapeutics, Inc. (LABT) — Form SCHEDULE 13G: Ownership over 5% (passive)

SC 13GLABTFiled Aug 14, 2026, 12:15 PM ET

About this filing

Lakewood-Amedex Biotherapeutics, Inc. (LABT) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Aug 14, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More LABT filings

8-K
Current report
Filed Sep 28, 2026
EFFECT
SEC filing
Filed Sep 24, 2026
S-1
Registration statement
Filed Sep 18, 2026
DRS
SEC filing
Filed Aug 21, 2026
424B3
Prospectus
Filed Aug 17, 2026
10-Q
Quarterly report
Filed Aug 13, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.